Search Results - "Makimoto, A."
-
1
Secondary neoplasms after retinoblastoma treatment: retrospective cohort study of 754 patients in Japan
Published in Japanese journal of clinical oncology (01-03-2011)“…Little is known about the incidence of secondary neoplasms among survivors of retinoblastoma in Japan. The objective of our study was to analyze the cumulative…”
Get full text
Journal Article -
2
Segregated graft-versus-tumor effect between CNS and non-CNS lesions of Ewing's sarcoma family of tumors
Published in Bone marrow transplantation (Basingstoke) (01-06-2008)Get full text
Journal Article -
3
Long-term low-dose acyclovir against varicella-zoster virus reactivation after allogeneic hematopoietic stem cell transplantation
Published in Bone marrow transplantation (Basingstoke) (01-10-2001)“…To evaluate the efficacy of long-term administration of acyclovir as prophylaxis against varicella-zoster virus (VZV) reactivation, we analyzed the medical…”
Get full text
Journal Article -
4
A multidisciplinary treatment strategy that includes high-dose chemotherapy for metastatic retinoblastoma without CNS involvement
Published in Bone marrow transplantation (Basingstoke) (01-04-2005)“…The prognosis of patients with metastatic retinoblastoma is poor with conventional chemotherapy and radiation. Since retinoblastoma is highly chemosensitive,…”
Get full text
Journal Article -
5
Late hemorrhagic cystitis after reduced-intensity hematopoietic stem cell transplantation (RIST)
Published in Bone marrow transplantation (Basingstoke) (01-12-2003)“…We reviewed medical records of 256 patients to investigate the frequency and characteristics of hemorrhagic cystitis (HC) associated with reduced-intensity…”
Get full text
Journal Article -
6
Pharmacokinetic and pharmacodynamic investigation of irinotecan hydrochloride in pediatric patients with recurrent or progressive solid tumors
Published in International journal of clinical pharmacology and therapeutics (01-05-2010)“…A multicenter Phase I/II study of Irinotecan hydrochloride (CPT-11; 40-45 mg/m(2)/dose) was conducted for the treatment of refractory pediatric solid tumors…”
Get full text
Journal Article -
7
Endogenous Interleukin-8 (IL-8) Surge in Granulocyte Colony-Stimulating Factor–Induced Peripheral Blood Stem Cell Mobilization
Published in Blood (15-02-1999)“…The relationship between stem cell mobilization with granulocyte colony-stimulating factor (G-CSF) and the endogenous production of interleukin-8 (IL-8),…”
Get full text
Journal Article -
8
Endogenous Interleukin-8 (IL-8) Surge in Granulocyte Colony-Stimulating Factor–Induced Peripheral Blood Stem Cell Mobilization
Published in Blood (15-02-1999)“…The relationship between stem cell mobilization with granulocyte colony-stimulating factor (G-CSF) and the endogenous production of interleukin-8 (IL-8),…”
Get full text
Journal Article -
9
Induction of graft-versus-autoimmune (GVA) disease effect against refractory psoriasis by complete donor-type chimerism and graft-versus-host disease after allogeneic hematopoietic stem cell transplantation
Published in Bone marrow transplantation (Basingstoke) (02-08-2003)“…A 67-year-old man with AML, who had a 21-year history of psoriasis without remission, received a reduced-intensity transplantation from an HLA-identical…”
Get full text
Journal Article -
10
Primary cutaneous aspergillosis caused by Aspergillus ustus following reduced-intensity stem cell transplantation
Published in Annals of hematology (01-10-2002)“…A 19-year-old woman with myelodysplastic syndrome underwent reduced-intensity stem cell transplantation [RIST: (cladribine 0.11 mg/kg for 6 days, busulfan 4…”
Get full text
Journal Article -
11
Suspected delayed immune recovery against cytomegalovirus after reduced-intensity stem cell transplantation using anti-thymocyte globulin
Published in Bone marrow transplantation (Basingstoke) (01-02-2002)“…A reduced-intensity hematopoietic stem cell transplantation (RIST) regimen was developed to induce immunosuppression to facilitate the engraftment of donor…”
Get full text
Journal Article -
12
Urgent need for a validated tumor response evaluation system for use in immunotherapy
Published in Bone marrow transplantation (Basingstoke) (01-01-2004)Get full text
Journal Article -
13
Clinical and pathological features of primary lymphoma of bone
Published in European journal of cancer supplements (2008)Get full text
Journal Article -
14
Intra-apheresis recruitment of blood progenitor cells in children
Published in Transfusion (Philadelphia, Pa.) (01-10-1998)“…BACKGROUND: Determination of the optimal duration of apheresis requires a careful examination of blood progenitor cell (BPC) kinetics during apheresis…”
Get full text
Journal Article -
15
Early full donor myeloid chimerism after reduced-intensity stem cell transplantation using a combination of fludarabine and busulfan
Published in Haematologica (Roma) (01-10-2001)“…Hematopoietic Stem Cell Transplant Unit, National Cancer Center Hospital, Tokyo, Japan. BACKGROUND AND OBJECTIVES: The aim of this study was to evaluate…”
Get full text
Journal Article -
16
-
17
Comparative analysis of engraftment after cryopreservation of peripheral blood stem cell autografts by controlled- versus uncontrolled-rate methods
Published in Bone marrow transplantation (Basingstoke) (01-06-1994)“…Peripheral blood stem/progenitor cells (PBSC) were cryopreserved by different methods and their clonogenic viabilities were compared. The traditional…”
Get more information
Journal Article -
18
New consecutive high-dose chemotherapy modality with fractionated blood stem cell support in the treatment of high-risk pediatric solid tumors : a feasibility study
Published in Bone marrow transplantation (Basingstoke) (01-01-1998)“…For the treatment of childhood solid tumors, we performed a pilot feasibility study of consecutive high-dose therapies, in which each course was followed by…”
Get full text
Journal Article -
19
Clinically applicable bulk isolation of blood CD34+ cells for autografting in children
Published in Bone marrow transplantation (Basingstoke) (01-11-1998)“…CD34+ cells were purified in bulk from apheresis-collected cells of children with cancer using monoclonal antibody (MoAb) and magnetic beads (Baxter ISOLEX…”
Get full text
Journal Article -
20
Feasibility and pharmacokinetic study of potential ABCG2 inihibitor, gefitinib (GB), in combination with irinotecan (IRN) for adolescents and young adults (AYA)
Published in Journal of clinical oncology (20-05-2011)“…Abstract only…”
Get full text
Journal Article